8-K current report · filed Oct 28, 2026

GE HealthCare (GEHC) 8-K Current Report: October 28, 2026

Item 5.02Item EX-99.1Item 2.02GEHC overview

Short answer

GE HealthCare (GEHC) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). GE HealthCare announced third-quarter 2026 financial results on October 28, 2026.

GE HealthCare 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • GE HealthCare announced third-quarter 2026 financial results on October 28, 2026
  • Detailed results, guidance, and management commentary are contained in Exhibit 99 press release

Item 5.02 · Departure/Election of Directors or Officers

  • Jeannette Bankes resigning as President and CEO, Patient Care Solutions
  • Departure effective November 15, 2026
  • Leadership transition creates execution risk for GE HealthCare’s Patient Care Solutions segment

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $5.5B, up 7.2%, with organic growth 6.2% across all segments
  • Adjusted EBIT margin 16.6%, up 180 bps, while adjusted EPS rose 25.1% to $1.34
  • Orders grew organically 4.0%, book-to-bill 1.03x, and backlog reached $23.7B, supporting forward demand visibility
  • Full-year guidance raised: organic growth ~4.0%, adjusted EPS $4.95-$5.05, free cash flow $1.6B+
  • Planned $945M cash SOFIE Biosciences acquisition, expected to close in first half of 2027, expands U.S. PET radiopharmaceutical distribution

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other GE HealthCare 8-K filings

Get the next GEHC 8-K as it lands

Follow GEHC for push alerts, or ask the research agent what this filing means.